Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets
- First Online:
- Cite this article as:
- Sredni, S.T., Bonaldo, M..F., Costa, F.F. et al. Childs Nerv Syst (2010) 26: 279. doi:10.1007/s00381-009-1028-y
- 288 Downloads
The aim of this study is to search for new therapeutic targets for atypical teratoid–rhabdoid tumors (ATRT).
To achieve this, we compared the expression of 365 microRNAs among ATRT, medulloblastomas, and normal brain.
MiR-221 and miR-222 were within the top differentially expressed microRNAs. The deregulated expression of miR221/222 was demonstrated to inhibit the expression of the tumor suppressor and inhibitor of cell cycle p27Kip1. Here, we demonstrated the negative regulation of p27Kip1 by miR-221/222 in ATRT using microarray, real-time reverse transcriptase polymerase chain reaction, and immunohistochemistry.
As anti-miR therapy was recently proposed as an alternative treatment for cancer, these findings suggest that anti-miR-221/222 therapy might have therapeutic potential in ATRT.